Analytical reference table
65 materials, one table.
Aliases, sequence, formula, molecular weight, CAS, form, sizes, storage and the latest lot's HPLC purity, sortable and exportable. Chemistry is compiled from the public literature for 45 single-molecule materials; blends list their components. Rows marked verify are awaiting the lab's confirmation.
65 of 65
| Adamax verify | Structured peptide | Lyophilized | 10mg, 5mg | −20 °C | from $40 | ||||||
| AOD-9604 | Linear peptide | AOD9604, hGH fragment 176-191 | Tyr-hGH(177-191) | C78H123N23O23S2 | 1815.1 | 221231-10-3 | Lyophilized | 10mg, 5mg | −20 °C | from $49 | |
| ARA-290 verify | Linear peptide | ARA290, cibinetide | pGlu-EQLERALNSS | C51H84N16O21 | 1257.3 | 1208243-50-8 | Lyophilized | 10mg | −20 °C | $64.99 | |
| BPC-157 | Linear peptide | BPC157, Body Protection Compound, PL 14736 | GEPPPGKPADDAGLV | C62H98N16O22 | 1419.5 | 137525-51-0 | Lyophilized | 10mg, 5mg | −20 °C | 99.83 | from $30 |
| BPC-157/TB-500 Blend bpc 157 + tb 500 thymosin beta 4 | Linear peptide | Lyophilized | 10/10mg | −20 °C | $64.99 | ||||||
| Cagrilintide verify | Incretin-pathway standard | cagri, AM833 | 37-residue amylin analogue, C20 diacid | C194H304N56O53 | 4409.0 | 1415456-99-3 | Lyophilized | 10mg, 5mg | −20 °C | from $40 | |
| CJC-1295 | Linear peptide | CJC1295, Mod GRF 1-29, CJC-1295 no DAC | Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH2 | C152H252N44O42 | 3367.9 | 863288-34-0 | Lyophilized | 10mg | −20 °C | $85 | |
| CJC-1295 + Ipamorelin Blend cjc 1295 + ipamorelin | Linear peptide | Lyophilized | 5mg/5mg | −20 °C | $69 | ||||||
| DSIP | Linear peptide | delta sleep-inducing peptide | WAGGDASGE | C35H48N10O15 | 848.8 | 62568-57-4 | Lyophilized | 10mg, 5mg | −20 °C | from $39 | |
| DSIP Nasal Spray | Nasal spray formulation | delta sleep-inducing peptide | WAGGDASGE | C35H48N10O15 | 848.8 | 62568-57-4 | 15 mL spray | 15 mg / 15 mL | 2 to 8 °C | $109 | |
| Epitalon | Linear peptide | epithalon, epithalone, AEDG | AEDG | C14H22N4O9 | 390.3 | 307297-39-8 | Lyophilized | 10mg | −20 °C | $40 | |
| Epithalon Nasal Spray | Nasal spray formulation | epithalon, epithalone, AEDG | AEDG | C14H22N4O9 | 390.3 | 307297-39-8 | 15 mL spray | 30 mg / 15 mL | 2 to 8 °C | $109 | |
| FOXO4-DRI verify | Structured peptide | FOXO4 D-retro-inverso | Lyophilized | 10mg | −20 °C | $99.99 | |||||
| GHK-Cu | Prefilled research pen | GHKCu, GHK Cu, copper peptide, copper tripeptide-1 | GHK · Cu(II) | C14H22CuN6O4 | 403.9 | 89030-95-5 | Pen | 50mg | −20 °C | $67.99 | |
| GHK-Cu | Copper peptide complex | GHKCu, GHK Cu, copper peptide, copper tripeptide-1 | GHK · Cu(II) | C14H22CuN6O4 | 403.9 | 89030-95-5 | Lyophilized | 100mg, 50mg | −20 °C | from $38 | |
| GHK-Cu Nasal Spray | Nasal spray formulation | GHKCu, GHK Cu, copper peptide, copper tripeptide-1 | GHK · Cu(II) | C14H22CuN6O4 | 403.9 | 89030-95-5 | 15 mL spray | 75 mg / 15 mL | 2 to 8 °C | $109 | |
| Glow bpc 157 + tb 500 thymosin beta 4 + ghk cu | Prefilled research pen | Pen | 70mg | −20 °C | $69.99 | ||||||
| GLOW 70 mg: GHK-Cu / BPC-157 / TB-500 ghk cu + bpc 157 + tb 500 thymosin beta 4 | Combination standard | Lyophilized | 70mg | −20 °C | $92 | ||||||
| GLOW BPC-157 + TB-500 Fragment + GHK-Cu bpc 157 + tb 500 thymosin beta 4 + ghk cu | Nasal spray formulation | 15 mL spray | 15 mg + 15 mg + 75 mg / 15 mL | 2 to 8 °C | $149 | ||||||
| GLP-2 | Prefilled research pen | Pen | 20mg | −20 °C | $67.99 | ||||||
| GLP-3 | Prefilled research pen | Pen | 20mg | −20 °C | $70.99 | ||||||
| Glutathione | Linear peptide | GSH, reduced glutathione | γ-Glu-Cys-Gly | C10H17N3O6S | 307.3 | 70-18-8 | Lyophilized | 1500mg | −20 °C | $89 | |
| IGF-LR3-1 verify | Structured peptide | IGF-1 LR3, Long R3 IGF-1 | 83-residue IGF-1 analogue, Arg3, N-terminal 13-residue extension | C990H1528N262O300S7 | 9111.0 | 946870-92-4 | Lyophilized | 1mg | −20 °C | $79.99 | |
| Ipamorelin | Linear peptide | NNC 26-0161 | Aib-His-D-2-Nal-D-Phe-Lys-NH2 | C38H49N9O5 | 711.9 | 170851-70-4 | Lyophilized | 10mg, 5mg | −20 °C | from $35 | |
| Kisspeptin | Linear peptide | kisspeptin-10, metastin 45-54 | YNWNSFGLRF-NH2 | C63H83N17O14 | 1302.4 | 374675-21-5 | Lyophilized | 10mg | −20 °C | $69 | |
| Klotho (alphaKlothoLR) verify | Recombinant protein | alpha-Klotho | Lyophilized | 10mg | −20 °C | $155 | |||||
| KLOW 80 mg: GHK-Cu / BPC-157 / TB-500 / KPV ghk cu + bpc 157 + tb 500 thymosin beta 4 + kpv | Combination standard | Lyophilized | 80mg | −20 °C | $114.99 | ||||||
| KPV verify | Linear peptide | alpha-MSH 11-13 | KPV | C16H31N5O4 | 357.5 | 67727-97-3 | Lyophilized | 10mg | −20 °C | $50 | |
| KPV Nasal Spray verify | Nasal spray formulation | alpha-MSH 11-13 | KPV | C16H31N5O4 | 357.5 | 67727-97-3 | 15 mL spray | 30 mg / 15 mL | 2 to 8 °C | $109 | |
| L-Carnitine | Metabolic standard | levocarnitine | Quaternary ammonium compound (not a peptide) | C7H15NO3 | 161.2 | 541-15-1 | Lyophilized | 600mg | −20 °C | $49.99 | |
| LL-37 | Linear peptide | LL37, cathelicidin | LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES | C205H340N60O53 | 4493.3 | 154947-66-7 | Lyophilized | 5mg | −20 °C | $49.99 | |
| Melanotan II | Structured peptide | MT2, MT-II, melanotan 2 | Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2 | C50H69N15O9 | 1024.2 | 121062-08-6 | Lyophilized | 10mg | −20 °C | $39.99 | |
| Melanotan II Nasal Spray | Nasal spray formulation | MT2, MT-II, melanotan 2 | Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2 | C50H69N15O9 | 1024.2 | 121062-08-6 | 15 mL spray | 15 mg / 15 mL | 2 to 8 °C | $109 | |
| MOTS-c | Linear peptide | MOTSc, MOTS c | MRWQEMGYIFYPRKLR | C101H152N28O22S2 | 2174.6 | 1627580-64-6 | Lyophilized | 10mg, 20mg, 40mg | −20 °C | from $49 | |
| MOTS-C Nasal Spray | Nasal spray formulation | MOTSc, MOTS c | MRWQEMGYIFYPRKLR | C101H152N28O22S2 | 2174.6 | 1627580-64-6 | 15 mL spray | 30 mg / 15 mL | 2 to 8 °C | $159 | |
| N-Acetyl Selank Amidate Nasal Spray verify | Nasal spray formulation | 15 mL spray | 30 mg / 15 mL | 2 to 8 °C | $109 | ||||||
| N-Acetyl Semax + N-Acetyl Selank Blend semax + selank verify | Nasal spray formulation | 15 mL spray | 30 mg + 30 mg / 15 mL | 2 to 8 °C | $149 | ||||||
| N-Acetyl Semax Amidate Nasal Spray verify | Nasal spray formulation | 15 mL spray | 30 mg / 15 mL | 2 to 8 °C | $109 | ||||||
| NAD+ | Prefilled research pen | NAD+, NAD, β-NAD | Dinucleotide coenzyme (not a peptide) | C21H27N7O14P2 | 663.4 | 53-84-9 | Pen | 500mg | −20 °C | $67.99 | |
| NAD+ (Nicotinamide Adenine Dinucleotide) | Coenzyme | NAD+, NAD, β-NAD | Dinucleotide coenzyme (not a peptide) | C21H27N7O14P2 | 663.4 | 53-84-9 | Lyophilized | 1000mg, 500mg | −20 °C | from $63.99 | |
| NAD+ Nasal Spray | Nasal spray formulation | NAD+, NAD, β-NAD | Dinucleotide coenzyme (not a peptide) | C21H27N7O14P2 | 663.4 | 53-84-9 | 15 mL spray | 750 mg / 15 mL | 2 to 8 °C | $139 | |
| Oxytocin | Structured peptide | CYIQNCPLG-NH2 (Cys1-Cys6 disulfide) | C43H66N12O12S2 | 1007.2 | 50-56-6 | Lyophilized | 10mg | −20 °C | $49.99 | ||
| PT-141 (Bremelanotide) | Structured peptide | PT141, PT 141, bremelanotide, Vyleesi | Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH | C50H68N14O10 | 1025.2 | 189691-06-3 | Lyophilized | 10mg | −20 °C | $49.99 | |
| PT-141 + Oxytocin Nasal Spray pt 141 bremelanotide + oxytocin | Nasal spray formulation | 15 mL spray | 15 mg + 7.5 mg / 15 mL | 2 to 8 °C | $149 | ||||||
| PT-141 Nasal Spray | Nasal spray formulation | PT141, PT 141, bremelanotide, Vyleesi | Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH | C50H68N14O10 | 1025.2 | 189691-06-3 | 15 mL spray | 30 mg / 15 mL | 2 to 8 °C | $129 | |
| Reduced Glutathione Nasal Spray | Nasal spray formulation | GSH, reduced glutathione | γ-Glu-Cys-Gly | C10H17N3O6S | 307.3 | 70-18-8 | 15 mL spray | 375 mg / 15 mL | 2 to 8 °C | $89 | |
| Retatrutide (GP-3) Reference Standard verify | Incretin-pathway standard | reta, GP-3, LY3437943 | 39-residue GIP/GLP-1/glucagon triple agonist | C221H342N46O68 | 4731.3 | 2381089-83-2 | Lyophilized | 10mg, 15mg, 20mg, 30mg, 5mg, 60mg | −20 °C | from $50 | |
| Selank | Linear peptide | TP-7 | TKPRPGP | C33H57N11O9 | 751.9 | 129954-34-3 | Lyophilized | 10mg, 5mg | −20 °C | from $30 | |
| Selank Nasal Spray | Nasal spray formulation | TP-7 | TKPRPGP | C33H57N11O9 | 751.9 | 129954-34-3 | 15 mL spray | 30 mg / 15 mL | 2 to 8 °C | $89 | |
| Semaglutide (GP-1) Reference Standard | Incretin-pathway standard | sema, GP-1 | GLP-1(7-37) analogue, Aib8, Arg34, Lys26 C18 diacid via γGlu-2xOEG | C187H291N45O59 | 4113.6 | 910463-68-2 | Lyophilized | 10mg, 15mg, 20mg, 30mg, 5mg | −20 °C | from $44 | |
| Semax | Linear peptide | ACTH 4-7 Pro-Gly-Pro | MEHFPGP | C37H51N9O10S | 813.9 | 80714-61-0 | Lyophilized | 10mg, 5mg | −20 °C | from $30 | |
| Semax Nasal Spray | Nasal spray formulation | ACTH 4-7 Pro-Gly-Pro | MEHFPGP | C37H51N9O10S | 813.9 | 80714-61-0 | 15 mL spray | 30 mg / 15 mL | 2 to 8 °C | $89 | |
| Sermorelin | Linear peptide | GRF 1-29, GHRH 1-29 | YADAIFTNSYRKVLGQLSARKLLQDIMSR-NH2 | C149H246N44O42S | 3357.9 | 86168-78-7 | Lyophilized | 10mg, 5mg | −20 °C | from $45 | |
| SS-31 | Linear peptide | SS31, elamipretide, MTP-131, Bendavia | D-Arg-Dmt-Lys-Phe-NH2 | C32H49N9O5 | 639.8 | 736992-21-5 | Lyophilized | 10mg | −20 °C | $100 | |
| SS-31 Nasal Spray | Nasal spray formulation | SS31, elamipretide, MTP-131, Bendavia | D-Arg-Dmt-Lys-Phe-NH2 | C32H49N9O5 | 639.8 | 736992-21-5 | 15 mL spray | 15 mg / 15 mL | 2 to 8 °C | $149 | |
| TB-500 (Thymosin Beta-4) verify | Linear peptide | TB500, TB 500, Thymosin beta-4 fragment | Ac-LKKTETQ | C38H68N10O14 | 889.0 | 885340-08-9 | Lyophilized | 10mg, 5mg | −20 °C | from $50 | |
| Tesamorelin | Linear peptide | TH9507, Egrifta | trans-3-hexenoyl-GHRH(1-44)-NH2 | C221H366N72O67S | 5135.9 | 218949-48-5 | Lyophilized | 10mg, 5mg | −20 °C | from $50 | |
| Tesamorelin/Ipamorelin tesamorelin + ipamorelin | Linear peptide | Lyophilized | 12mg/6mg, 18mg/12mg | −20 °C | from $35 | ||||||
| Thymalin verify | Combination standard | thymus extract | Lyophilized | 10mg | −20 °C | $55 | |||||
| Thymosin Alpha-1 | Linear peptide | Tα1, thymalfasin, Zadaxin | Ac-SDAAVDTSSEITTKDLKEKKEVVEEAEN | C129H215N33O55 | 3108.3 | 62304-98-7 | Lyophilized | 10mg | −20 °C | $69.99 | |
| Tirzepatide (GP-2) Reference Standard | Incretin-pathway standard | tirz, GP-2 | 39-residue GIP/GLP-1 dual agonist, Aib2, Aib13, Lys20 C20 diacid via γGlu-2xOEG | C225H348N48O68 | 4813.5 | 2023788-19-2 | Lyophilized | 10mg, 15mg, 20mg, 30mg, 5mg, 60mg | −20 °C | from $39 | |
| VIP | Linear peptide | vasoactive intestinal peptide | HSDAVFTDNYTRLRKQMAVKKYLNSILN-NH2 | C147H237N43O43S | 3326.8 | 37221-79-7 | Lyophilized | 10mg | −20 °C | $65.99 | |
| Wolverine bpc 157 + tb 500 thymosin beta 4 | Prefilled research pen | Pen | 10+10mg | −20 °C | $74.99 | ||||||
| Wolverine bpc 157 + tb 500 thymosin beta 4 | Combination standard | Lyophilized | 10mg, 20mg | −20 °C | 99.75 | from $70 | |||||
| Wolverine BPC-157 + TB-500 Fragment bpc 157 + tb 500 thymosin beta 4 | Nasal spray formulation | 15 mL spray | 15 mg + 15 mg / 15 mL | 2 to 8 °C | $129 |
Research use only. This table describes materials supplied for in-vitro research and analytical method development. Nothing here is dosing or administration information.